Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Balli

Showing results (441-450 of 689) with videos related to

Pageof 69
Sort By:
Journal of Immunotherapy (Hagerstown, Md. : 1997)|April 13, 2026
Side Effect Management of Immune-related Hepatotoxicity Due to Immune Checkpoint Inhibitors: A Multicenter Study by the Turkish Oncology Group (TOG)Ozden Demir, Bulent Cetin, Ali Alkan, et al.
Nature Communications|March 3, 2023
The Wnt/TCF7L1 transcriptional repressor axis drives primitive endoderm formation by antagonizing naive and formative pluripotencyParaskevi Athanasouli, Martina Balli, Anchel De Jaime-Soguero, et al.
ESMO Open|November 21, 2023
Nivolumab plus chemotherapy in first-line metastatic non-small-cell lung cancer: results of the phase III CheckMate 227 Part 2 trialH Borghaei, K J O'Byrne, L Paz-Ares, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 8, 2016
Detection of Therapeutically Targetable Driver and Resistance Mutations in Lung Cancer Patients by Next-Generation Sequencing of Cell-Free Circulating Tumor DNAJeffrey C Thompson, Stephanie S Yee, Andrea B Troxel, et al.
Nature Medicine|October 30, 2023
Association between pathologic response and survival after neoadjuvant therapy in lung cancerJulie Stein Deutsch, Ashley Cimino-Mathews, Elizabeth Thompson, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 26, 2026
Early Detriment Analysis of First-Line Nivolumab plus Ipilimumab-Based Therapy in Patients with Metastatic Non-Small Cell Lung CancerHossein Borghaei, David Balli, Luis G Paz-Ares, et al.
World Journal of Gastrointestinal Surgery|June 12, 2025
Results of endoscopic retrograde cholangiopancreatography procedures at surgical clinics: A multicenter observational study in TürkiyeSezgin Yilmaz, Esat Taylan Ugurlu, Alpen Yahya Gumusoglu, et al.
Canadian Journal of Gastroenterology & Hepatology|July 17, 2018
Macroscopic Portal Vein Thrombosis in HCC PatientsHikmet Akkiz, Brian I Carr, Sedef Kuran, et al.
EMBO Reports|July 29, 2021
Calcium signaling induces a partial EMTRobert J Norgard, Jason R Pitarresi, Ravikanth Maddipati, et al.
The New England Journal of Medicine|April 11, 2022
Neoadjuvant Nivolumab plus Chemotherapy in Resectable Lung CancerPatrick M Forde, Jonathan Spicer, Shun Lu, et al.
Pageof 69

Showing results (441-450 of 689) with videos related to

Sort By:
Pageof 69
Journal of Immunotherapy (Hagerstown, Md. : 1997)|April 13, 2026
Side Effect Management of Immune-related Hepatotoxicity Due to Immune Checkpoint Inhibitors: A Multicenter Study by the Turkish Oncology Group (TOG)Ozden Demir, Bulent Cetin, Ali Alkan, et al.
Nature Communications|March 3, 2023
The Wnt/TCF7L1 transcriptional repressor axis drives primitive endoderm formation by antagonizing naive and formative pluripotencyParaskevi Athanasouli, Martina Balli, Anchel De Jaime-Soguero, et al.
ESMO Open|November 21, 2023
Nivolumab plus chemotherapy in first-line metastatic non-small-cell lung cancer: results of the phase III CheckMate 227 Part 2 trialH Borghaei, K J O'Byrne, L Paz-Ares, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 8, 2016
Detection of Therapeutically Targetable Driver and Resistance Mutations in Lung Cancer Patients by Next-Generation Sequencing of Cell-Free Circulating Tumor DNAJeffrey C Thompson, Stephanie S Yee, Andrea B Troxel, et al.
Nature Medicine|October 30, 2023
Association between pathologic response and survival after neoadjuvant therapy in lung cancerJulie Stein Deutsch, Ashley Cimino-Mathews, Elizabeth Thompson, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 26, 2026
Early Detriment Analysis of First-Line Nivolumab plus Ipilimumab-Based Therapy in Patients with Metastatic Non-Small Cell Lung CancerHossein Borghaei, David Balli, Luis G Paz-Ares, et al.
World Journal of Gastrointestinal Surgery|June 12, 2025
Results of endoscopic retrograde cholangiopancreatography procedures at surgical clinics: A multicenter observational study in TürkiyeSezgin Yilmaz, Esat Taylan Ugurlu, Alpen Yahya Gumusoglu, et al.
Canadian Journal of Gastroenterology & Hepatology|July 17, 2018
Macroscopic Portal Vein Thrombosis in HCC PatientsHikmet Akkiz, Brian I Carr, Sedef Kuran, et al.
EMBO Reports|July 29, 2021
Calcium signaling induces a partial EMTRobert J Norgard, Jason R Pitarresi, Ravikanth Maddipati, et al.
The New England Journal of Medicine|April 11, 2022
Neoadjuvant Nivolumab plus Chemotherapy in Resectable Lung CancerPatrick M Forde, Jonathan Spicer, Shun Lu, et al.
Pageof 69